Abstract
Clostridium botulinum and Clostridium novyi are pathogenic anaerobes that are characterized by their ability to produce powerful toxins lethal to man and animals. The different types of C. botulinum are recognized specifically for their ability to produce neurotoxins that are responsible for wound, toxicoinfectious, and food-borne forms of botulism in man and animals. Members of C. novyi do not produce neurotoxins, but they produce other lethal toxins and biologically active substances active in gas gangrene infections found in humans and animals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, M.H. 1959. Bacteriophages. New York: Wiley.
Aktories, K., S. Rösener, U. Blaschke, and G.S. Chhatwal. 1988. Botulinum ADP-ribosyl-tranferase C3. Purification of the enzyme and characterization of the ADP-ribosylation reaction in platelet membranes. Eur. J. Biochem. 172: 445–50.
Aktories, K., U. Weiler, and G.S. Chhatwal. 1987. Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from C2 toxin. Fed. Eur. Biochem. Soc. Lett. 212:109–113.
Aureli, P., L. Fenicia, B. Pasolini, M. Gionfranceschi, L.M. McCroskey, and C.L. Hatheway. 1986. Two cases of type E infant botulism in Italy caused by neurotoxigenic Clostridium butyricum. J. Inject. Dis. 154:207–211.
Betty, I., D. Buntain, and P.D. Waller. 1964. Clostridium oedematiens: a cause of sudden death in sheep, cattle, and pigs. Vet. Rec. 76:1115–1116.
Clowes, R C. 1972. Molecular structure of bacterial plasmids. Bacteriol. Rev. 36:361–405.
Dolman, C.E. and E. Chang. 1972. Bacteriophages of Clostridium botulinum. Can. J. Microbiol. 18:67–76.
Dowell, V. and M. Dezfulian. 1981. Physiological characteristics of Clostridium botulinum and development of practical isolation and identification procedures. In: Biomedical Aspects of Botulism, G. Lewis, ed., pp. 205–216. New York, Academic Press.
Eklund, M.W., and F.T. Poysky. 1972. Activation of a toxic component of Clostridium botulinum types C and D by trypsin. Appl. Microbiol. 24:108–113.
Eklund, M.W., and F.T. Poysky. 1974. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages. Appl. Microbiol. 27:251–258.
Eklund, M.W., F.T. Poysky, and E.S. Boatman. 1969. Bacteriophages of Clostridium botulinum types A, B, E, and F and nontoxigenic strains resembling type E. J. Virol. 3:270–274.
Eklund, M.W., F.T. Poysky, and S.M. Reed. 1972. Bacteriophage and the toxigenicity of Clostridium botulinum type D. Nature (London) New Biology 235:16–17.
Eklund, M.W., F.T. Poysky, S.M. Reed, and C.A. Smith. 1971. Bacteriophages and toxigenicity of Clostridium botulinum type C. Science 172:480–482.
Eklund, M.W., F.T. Poysky, J.A. Meyers, and G.A. Pelroy. 1974. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage. Science 186:456–458.
Eklund, M.W., F.T. Poysky, M.E. Peterson, and J.A. Meyers. 1976. Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B. Infect. Immun. 14:793–803.
Eklund, M.W., F.T. Poysky, L.M. Mseitif, and M.S. Strom. 1988. Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G. Appl. Environ. Microbiol. 54:1405–1408.
Fujii, M., K. Oguma, N. Yokosawa, K. Kimura, and K. Tsuzuki. 1988. Characteristics of bacteriophage nucleic acids obtained from Clostridium botulinum types C and D. Appl. Environ. Microbiol. 54:69–73.
Giménez, D. F. 1984. Clostridium botulinum subtype Ba. Zentralbl. Bakteriol. Hyg. A257:68–72.
Gimenez, D.F., and A.S. Ciccarelli. 1978. New strains of Clostridium botulinum subtype Af. Zentralbl. Bakteriol. Parasitenk. Infektionskr. Hyg. 1 Orig. 240:215–220.
Hall, J.D., L.M. McCroskey, B.J. Pincomb, and C.L. Hatheway. 1985. Isolation of an organism which produces type E botulinal toxin for an infant with botulism.J. Clin. Microbiol. 21:654–655.
Hariharan, H. and W.R. Mitchell. 1976. Observations on bacteriophages of Clostridium botulinum type C isolates from different sources and the role of certain phages in toxigenicity. Appl. Environ. Microbiol. 32:145–158.
Hauser, D., M.W. Eklund, H. Kurazono, T. Binz, H. Niemann, D.M. Gill, P. Boquet, and M.R. Popoff. 1990. Nucleotide sequence of Clostridium botulinum C neurotoxin. Nucleic Acids Res. 18:4924.
Holdeman, L.V., and J.B. Brooks. 1968. Variation among strains of Clostridium botulinum and related Clostridia. In: Proceedings of the First U.S.Japan Conference on Toxic Microorganisms, A. Herzberg, ed., pp. 278–286. Washington, DC.: U.S. Government Printing Office.
Inoue, K. and H. Iida. 1968. Bacteriophages of Clostridium botulinum. J. Virol. 2:537–540.
Inoue, K. and H. Iida. 1970. Conversion to toxigenicity in Clostridium botulinum type C. pn. J. Microbiol. 14:87–89.
Inoue, K. and J. Iida. 1971. Phage conversion of toxigenicity in Clostridium botulinum types C and D. Jpn. J. Med. Sci. 24:53–56.
Jansen, B.C. 1971. The toxic antigenic factors produced by Clostridium botulinum types C and D. Onderstepoort J. Vet. Res. 38:93–98.
Kautter, D.A., S.M. Harmon, R.K. Lynt Jr., and T. Lilly Jr. 1966. Antagonistic effect of Clostridium botulinum type E by organisms resembling it. Appl. Microbiol. 14:616–622.
Lewis, G.E., S.S. Kalinski, D.W. Reichard, and J.F. Metzer. 1981. Detection of Clostridium botulinum type G toxin by enzyme-linked immunosorbent assay. Appl. Environ. Microbiol. 42:1018–1022.
McCroskey, L.M., and C.L. Hatheway. 1984. Atypical strains of Clostridium botulinum isolated from specimens in infant botulism cases. In: Abstracts, Annual Meeting of the American Society for Microbiology, C159, p. 263. Washington, D.C.: American Society for Microbiology.
McCroskey, L.M., C.L. Hatheway, L. Fenicia, B. Pasolini, and P. Aureli. 1986. Characterization of an organism that produces type E botulinal toxin that resembles Clostridium butyricum from feces of an infant with type E botulism. J. Clin. Microbiol. 23:201–202.
Nakamura, S., T. Serikawa, K. Yamakawa, S. Nishida, S. Kozaki, G. Sakaguchi. 1978. Sporulation and C2 toxin production by Clostridium botulinum type C strains producing no C1 toxin. Microbiol. Immunol. 22:591–596.
Nakamura, S., K. Takematsu, and S. Nishida. 1975. Susceptibility to Mitomycin C and lecithinase activities of Clostridium oedematiens (C. novyi) types B and D.J. Med. Microbiol. 8:289–297.
Nakane, A., K. Oguma, M. Shiozoka, and H. Iida. 1978. Production of trypsin activable toxin components by Clostridium botulinum types C and D. Jpn. J. Med. Sci. 31:166–169.
Oakley, C.L. and G.H. Warrack. 1959. The soluble antigens of Clostridium oedematiens type D (Cl. haemolyticum). J. Pathol. Bacteriol. 78:543–551.
Oguma, K., H. Iida, and K. Inoue. 1973. Bacteriophage and toxigenicity of Clostridium botulinum: An additional evidence for phage conversion. Jpn. J. Microbiol. 17:425–426.
Oguma, K., M. Shiozaki, and H. Iida. 1976. Phage conversion to hemagglutinin production in Clostridium botulinum types C and D. Infect. Immun. 14:597–602.
Ohishi, I. and B.R. Dasgupta. 1987. Molecular structure and biological activities of Clostridium botulinum C2 toxin. In: Avian Botulism: An International Perspective, M.W. Eklund and V.R. Dowell Jr., eds., pp. 223–247. Springfield, IL: Thomas.
Ohishi, I., M. Iwasaka, and G. Sakaguchi. 1981. Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimilar protein components. Infect. Immun. 31:890–895.
Popoff, M.R., P. Boquet, D.M. Gill, and M.W. Eklund. 1990. DNA sequence of exoenzyme C3, and ADP ribosyltransferase encoded by Clostridium botulinum C and D phages. Nucleic Acids Res. 18:1291.
Poumeyrol, M., J. Billon, F. Delille, C. Haas, A. Marmonier, and M. Sebald. 1983. Intoxication botulique mortelle due a une souche de Clostridium botulinum de type AB. Med. Malad. Infect. 13:750–754.
Rubin, E.J., D.M. Gill, P. Boquet, and M.R. Popoff. 1988. Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. Mol. Cell. Biol. 8:418–426.
Rutter, J.M., and J.G. Collee. 1969. Studies on the soluble antigens of Clostridium oedematiens (Cl. novyi). J. Med. Microbiol. 2:395–417.
Sakaguchi, G., S. Sakaguchi, S. Kozai, and M. Takahashi. 1986. Purification and some properties of Clostridium botulinum type AB toxin. Fed. Eur. Microbiol. Soc. Microbiol. Lett. 33:23–29.
Schallehn, G. and M.W. Eklund. 1980. Conversion of Clostridium novyi type D (C. haemolyticum) to alpha toxin production by phages of C. novyi type A. Fed. Eur. Microbiol. Soc. Microbiol. Lett. 7:83–86.
Schallehn, G., M.W. Eklund, and H. Brandis. 1980. Zur phagenkonversion von Clostridium novyi typ A. Zentralbl. Bakteriol. Hyg. 1 Abt. Orig. A 247:95–100.
Scott, V.N., and D.L. Duncan. 1978. Cryptic plasmids in Clostridium botulinum and C. botulinum-like organisms. Fed. Eur. Microbiol. Soc. Microbiol. Lett. 4:55–58.
Simpson, L.L. 1982. A comparison of pharmacological properties of Clostridium botulinum type C1 and C2 toxins.J. Pharmacol. Exp. Ther. 223: 695–701.
Simpson, L.L. 1987. The pathophysiological actions of the binary toxin produced by Clostridium botulinum. In: Avian Botulism: An International Perspective, M.W. Eklund and V.R. Dowell Jr., eds., pp. 249–264. Springfield, IL: Thomas.
Smith, L.D. 1975. The Pathogenic Anaerobic Bacteria. Springfield, IL: Thomas.
Smith, L. D. 1977. Botulism: The Organism, Its Toxin, the Disease. Springfield, IL: Thomas.
Smith, L.D., and L.V. Holdeman. 1968. The Pathogenic Anaerobic Bacteria. Springfield, IL: Thomas.
Smith, L.D., and H. Sugiyama. 1988. Botulism. Springfield, IL: Thomas.
Strom, M.S., M.W. Eklund, and F.T. Poysky. 1984. Plasmids in Clostridium botulinum and related species. Appl. Environ. Microbiol. 48:956–963.
Suen, J.C., C.L. Hatheway, A.G. Steigerwalt, and D.J. Brenner. 1988. Clostridium argentinense sp. nov.: a genetically homogenous group composed of all strains of Clostridium botulinum toxin type G and some nontoxigenic strains previously identified as Clostridium subterminale or Clostridium hastiforme. Int. J. Syst. Bacterial. 38:375–381.
Sugiyama, H., D. Mizutani, and K.W. Yang. 1972. Basis of type A and F toxicities of Clostridium botulinum strain 84. Proc. Soc. Exp. Biol. Med. 191:1063–1067.
Vinet, G., L. Berthiaume, and V. Fredette. 1968. Un bacteriophage dans une culture de C. botulinum C. Rev. Can. Biol. 27:73–74.
Weickert, M.J., G.H. Chambliss, and H. Sugiyama. 1986. Production of toxin by Clostridium botulinum type A strains cured of plasmids. Appl. Environ. Microbiol. 51:52–56.
Williams, B.M. 1964. Clostridium oedematiens infection (Black Disease and Bacillary Haemoglobinuria) of cattle in Mid-Wales. Vet. Rec. 76:591–596.
Willis, A.T. 1964. Anaerobic Bacteriology in Clinical Medicine. Washington, D.C.: Butterworths.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Eklund, M.W. (1993). The Role of Bacteriophages and Plasmids in the Production of Toxins and Other Biologically Active Substances by Clostridium botulinum and Clostridium novyi . In: Sebald, M. (eds) Genetics and Molecular Biology of Anaerobic Bacteria. Brock/Springer Series in Contemporary Bioscience. Springer, New York, NY. https://doi.org/10.1007/978-1-4615-7087-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-7087-5_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4615-7089-9
Online ISBN: 978-1-4615-7087-5
eBook Packages: Springer Book Archive